论文部分内容阅读
目的:探讨新型标准经皮肾镜取石术(PCNL)和微创经皮肾镜取石术(MPCNL)治疗肾脏下盏结石的安全性和疗效。方法:回顾性分析68例肾脏下盏结石的患者临床资料,采用新型肾镜治疗31例,微创经皮肾镜治疗37例;Ⅰ期碎石63例,选择中盏通道28例,下盏通道40例。结果:新型肾镜手术时间(2.18±0.57)h,平均住院时间(11.65±2.18)天;微创肾镜手术时间(1.89±0.56)h,平均住院时间(10.57±2.41)天,二者相比差异无统计学意义。术后复查KUB平片,57例排净结石,结石清除率为83.8%(57/68);残石11例,再次PCNL 5例,带D-J管体外碎石6例,无严重并发症出现。结论:新型标准经皮肾镜取石术和微创经皮肾镜取石术治疗肾脏下盏结石是有效、可行的,是治疗下盏结石的合适选择。
Objective: To explore the safety and efficacy of the new standard percutaneous nephrolithotomy (PCNL) and minimally invasive percutaneous nephrolithotomy (MPCNL) in the treatment of lower kidney stones. Methods: A retrospective analysis of 68 cases of renal calyceal stones in patients with clinical data, the use of new nephrosty in 31 cases, minimally invasive percutaneous nephrolithotomy in 37 cases; Ⅰ gravel in 63 cases, the choice of channel in 28 cases, the next light Channel 40 cases. Results: The average length of hospitalization was (2.18 ± 0.57) h, the average length of hospital stay was (11.65 ± 2.18) days, the duration of minimally invasive nephroscopy (1.89 ± 0.56) h, the average length of hospital stay (10.57 ± 2.41) days, The difference was not statistically significant. Postoperative KUB plain film, 57 cases of clean stones, stone clearance rate was 83.8% (57/68); residual stone in 11 cases, again PCNL in 5 cases, with D-J tube in vitro gravel in 6 cases, no serious complications. Conclusion: The new standard percutaneous nephrolithotomy and minimally invasive percutaneous nephrolithotomy in the treatment of lower kidney stones are effective and feasible, which is a suitable choice for treating lower calculus.